These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38166779)

  • 1. The current status of clinical trials on cancer and age disparities among the most common cancer trial participants.
    Zhao S; Miao M; Wang Q; Zhao H; Yang H; Wang X
    BMC Cancer; 2024 Jan; 24(1):30. PubMed ID: 38166779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.
    Ludmir EB; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Mandel JJ; Lin SH; Smith BD; Smith GL; VanderWalde NA; Minsky BD; Koong AC; Stinchcombe TE; Jagsi R; Gomez DR; Thomas CR; Fuller CD
    JAMA Oncol; 2019 Dec; 5(12):1769-1773. PubMed ID: 31158272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
    Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
    Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
    Murthy VH; Krumholz HM; Gross CP
    JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of Patients in Ongoing Clinical Trials on Lung Cancer.
    Schulkes KJ; Nguyen C; van den Bos F; van Elden LJ; Hamaker ME
    Lung; 2016 Dec; 194(6):967-974. PubMed ID: 27650509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older cancer patients in cancer clinical trials are underrepresented. Systematic literature review of almost 5000 meta- and pooled analyses of phase III randomized trials of survival from breast, prostate and lung cancer.
    Dunn C; Wilson A; Sitas F
    Cancer Epidemiol; 2017 Dec; 51():113-117. PubMed ID: 29126091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
    Pang HH; Wang X; Stinchcombe TE; Wong ML; Cheng P; Ganti AK; Sargent DJ; Zhang Y; Hu C; Mandrekar SJ; Redman MW; Manola JB; Schilsky RL; Cohen HJ; Bradley JD; Adjei AA; Gandara D; Ramalingam SS; Vokes EE
    J Clin Oncol; 2016 Nov; 34(33):3992-3999. PubMed ID: 27646951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis.
    Riaz IB; Islam M; Ikram W; Naqvi SAA; Maqsood H; Saleem Y; Riaz A; Ravi P; Wang Z; Hussain SA; Warner JL; Odedina FT; Duma N; Singh P; Kehl KL; Kamran SC; Murad MH; Landman A; Van Allen E; Bryce AH
    JAMA Oncol; 2023 Feb; 9(2):180-187. PubMed ID: 36416812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
    Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
    BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of prior cancer on non-small cell lung cancer trial eligibility.
    Herman M; Liu Z; Shepherd FA; Leighl N; Liu G; Bradbury PA
    Cancer Med; 2021 Jul; 10(14):4814-4822. PubMed ID: 34145985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
    Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
    JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in Breast, Lung, and Cervical Cancer Trials Worldwide.
    Ramaswami R; Paulino E; Barrichello A; Nogueira-Rodrigues A; Bukowski A; St Louis J; Goss PE
    J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer trial enrollment after state-mandated reimbursement.
    Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
    J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in phase 1 cancer clinical trial enrollment.
    Perni S; Moy B; Nipp RD
    Cancer; 2021 Dec; 127(23):4464-4469. PubMed ID: 34379799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
    Gross CP; Filardo G; Mayne ST; Krumholz HM
    Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of Patients From Racial and Ethnic Minority Groups in Phase 1 Early Cancer Drug Development Trials in the US, 2000-2018.
    Dunlop H; Fitzpatrick E; Kurti K; Deeb S; Gillespie EF; Dover L; Yerramilli D; Gomez SL; Chino F; Tsai CJ
    JAMA Netw Open; 2022 Nov; 5(11):e2239884. PubMed ID: 36326764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
    Lacey JV; Kreimer AR; Buys SS; Marcus PM; Chang SC; Leitzmann MF; Hoover RN; Prorok PC; Berg CD; Hartge P;
    BMC Cancer; 2009 Mar; 9():84. PubMed ID: 19292893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.